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Monitoring type 2 diabetes from 
volatile faecal metabolome in 
Cushing’s syndrome and single 
Afmid mouse models via a 
longitudinal study
Célia Lourenço  1,2, Darren Kelly3, Jack cantillon3, Michael cauchi3, Marianne A. Yon4, 
Liz Bentley4, Roger D. cox  4 & Claire turner 1,5*
The analysis of volatile organic compounds (VOCs) as a non-invasive method for disease monitoring, 
such as type 2 diabetes (T2D) has shown potential over the years although not yet set in clinical 
practice. Longitudinal studies to date are limited and the understanding of the underlying VOC emission 
over the age is poorly understood. This study investigated longitudinal changes in VOCs present in 
faecal headspace in two mouse models of T2D – Cushing’s syndrome and single Afmid knockout mice. 
Longitudinal changes in bodyweight, blood glucose levels and plasma insulin concentration were also 
reported. Faecal headspace analysis was carried out using selected ion flow tube mass spectrometry 
(SIFT-MS) and thermal desorption coupled to gas chromatography-mass spectrometry (TD-GC-MS). 
Multivariate data analysis of the VOC profile showed differences mainly in acetic acid and butyric acid 
able to discriminate the groups Afmid and Cushing’s mice. Moreover, multivariate data analysis revealed 
statistically significant differences in VOCs between Cushing’s mice/wild-type (WT) littermates, mainly 
short-chain fatty acids (SCFAs), ketones, and alcohols, and longitudinal differences mainly attributed to 
methanol, ethanol and acetone. Afmid mice did not present statistically significant differences in their 
volatile faecal metabolome when compared to their respective WT littermates. The findings suggested 
that mice developed a diabetic phenotype and that the altered VOC profile may imply a related change 
in gut microbiota, particularly in Cushing’s mice. Furthermore, this study provided major evidence of 
age-related changes on the volatile profile of diabetic mice.
Volatile organic compounds (VOCs) are produced as a consequence of endogenous metabolic activities and 
these can potentially be used as an alternative non-invasive approach to assist in the diagnosis or in monitoring 
the progress of disease. The biochemical origin of VOCs in exhaled breath, skin, urine and faecal headspace in 
rodent models is far from being well understood, and published literature is scarce. Breath analysis in mice is 
complex, the sampling is challenging, and the detection of VOC at trace concentration with enough sensitivity is 
problematic1–6.
Changes in VOCs emitted from stools can provide insight into the metabolic functions of the gut microbiota. 
Gut microbiota are thought to influence glucose and energy metabolism through the production of short-chain 
fatty acids (SCFAs). These volatile SCFAs include butyric acid, acetic acid, propionic acid, formic acid, isobu-
tyric acid, valeric acid, isovaleric acid, and caproic acids, although acetate, propionate and butyrate make up 90 
to 95% of SCFAs within the gut7,8. These fermentation products (SCFAs) are mainly generated from gut bac-
terial degradation of undigested dietary carbohydrates, along with the production of CO2, H2, and CH49. In 
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addition, amino acids (valine, leucine and isoleucine) can be further degraded into isobutyrate, isovalerate and 
2-methylbutyrate10. The composition of the gut microbiota is subject to genetic and environmental factors and 
notably it changes with age11. Longitudinal studies are scarce in literature and these yield numerous advantages 
compared to a single-cohort, such as assessing intra-individual variability, and in providing information about 
the onset and progress of disease.
Type 2 diabetes is a metabolic disease which has been attributed to changes in diet, poor physical activity, 
life-style and genetic predisposition, while more recently there is increasing evidence of a link between metabolic 
diseases and gut microbiota composition, with microbial metabolites having a major influence on host physiol-
ogy. Alterations to the gut microbiome have been linked to obesity, insulin resistance and type 2 diabetes12–16. 
However, whether gut microbiota plays an underlying role in the biological mechanisms that leads to the onset of 
metabolic diseases is unknown, and the understanding of such metabolic pathways in humans is limited. There 
is evidence of changes in the composition of faecal microbiota of type-2 diabetic patients when compared to 
non-diabetic subjects, where the relative abundance of bacterial species Firmicutes was significantly lower, while 
the proportion of Bacteroidetes and Proteobacteria was somewhat higher in diabetics compared to non-diabetic 
controls17.
Initial studies using mouse models are useful to provide insight about the disease at controlled conditions. The 
mouse model of Cushing’s syndrome used in this study is a N-ethyl-N-nitrosourea (ENU) chemically induced 
point mutation in the Crh promoter (the point mutation is inherited) and is a model with many of the features 
of type 2 diabetes18. These Cushing´s mice develop excessive circulating glucocorticoid concentrations in the 
body. Glucocorticoid is involved in the metabolism of carbohydrates, proteins and fats. As a consequence, mice 
are prone to develop obesity, hyperglycaemia, and insulin resistance, along with hair loss, thin skin and low bone 
mineral density6,18,19.
The enzyme arylformamidase (Afmid), also known as kynurenine formamidase participates in tryptophan 
metabolism, which in turn regulates many functions including pancreatic secretion, among others20. The Afmid 
knockout mice have been used to further investigate possible links between abnormal tryptophan metabolism 
and diabetes. The phenotype of these mice include a defect in glucose stimulated insulin secretion and reduced 
islet mass with age. These mice show impaired glucose tolerance, although their insulin sensitivity is unchanged 
when compared to wild-type (WT) animals6,21.
Metabolomics enables the exploration of disease-related metabolites, the so-called unique fingerprint 
of VOCs, through the aid of highly sensitive detection methods. Selected ion flow tube mass spectrometry 
(SIFT-MS) and thermal desorption coupled to gas chromatography-mass spectrometry (TD-GC-MS) have been 
widely used for untargeted analysis, and when combined these techniques provide a powerful approach for the 
detection and identification of metabolites in a biological sample22–26. In the present study we investigated the 
longitudinal changes in volatile faecal metabolites in mouse models of diabetes acquired either by SIFT-MS and 
TD-GC-MS. We employed multivariate statistics to demonstrate that differences in VOCs can accurately classify 
samples based upon phenotype. This is a novel piece of work that aimed to study the progress of diabetes in mice 
and to understand the gut metabolomics through the analysis of the volatile faecal profile and through the aid of 
highly sensitive analytical techniques.
Results and Discussion
The onset of obesity and dysregulation of plasma insulin and blood glucose. A student’s t-test 
was used to compare the mean score of bodyweights (normally distributed) between Cushing’s (het) mice and 
WT littermates and between sex-matched groups. The mutation had statistically significant effects on bodyweight 
(Fig. 1A) in agreement with published literature18. Female mutant (het) mice were significantly heavier (p < 0.001) 
than the WT littermates on a B6-C3PDE background. While Cushing’s (het) male mice were significantly heavier 
than the respective WT littermates from 8 to 12 weeks of age. From 12 weeks onwards, Cushing’s (het) male mice 
developed increasing and detrimental levels of blood glucose (Fig. 1C) which in turn triggers the decrease in 
bodyweight of the animals. A one-way repeated measure ANOVA with a Bonferroni post-hoc test was conducted 
to compare the animal’s bodyweight throughout the age. The results indicated that either for females or males the 
bodyweight of the animals significantly changed over the four months of study (p < 0.001).
Disease was tracked for Afmid (hom) mice and their respective WT littermates across three time points, 8, 
12 and 16 weeks of age (Fig. 1B). A Mann Whitney U test was used to compare the mean score of bodyweights 
between Afmid mice and WT littermates and between sex-matched groups. The non-parametric Friedman test 
(repeated measures) combined with individual post-hoc tests, i.e. Wilcoxon Signed Rank Test using a Bonferroni 
adjusted p value (p < 0.001), was used to compare the animal’s bodyweight over the age and to establish the sta-
tistically significant difference among the three time points. The results indicated that the bodyweight of the ani-
mals significantly changed over the age (p < 0.001), although there is no significant difference in the bodyweight 
between Afmid (hom) and WT littermates (Fig. 1B). Afmid (hom) male mice are significantly heavier (p < 0.05) 
than females over the three time points. Diet is a major factor that drives gut microbiota composition and the 
microbial generated metabolites27,28. In this study, all the animals (het, hom and WT) were under the same diet 
although we do not know whether diabetic animals ate the same amount as their respective WT littermates.
In Cushing’s mice, the mutation had statistically significant (p < 0.05) effects on blood glucose. The data indi-
cated that male and female mutant (het) mice had hyperglycaemia (blood glucose > 11.1 mmol L−1) by the age of 
16 weeks (Fig. 1C). In addition, the Cushing’s male mice developed significant increased concentrations of blood 
glucose from 16 weeks of age compared to WT littermates. Blood glucose sampling in mice induces stress in the 
animals and blood glucose variability might arise from that fact. In addition, some mice are more susceptible 
to obesity and diabetes than others, and insulin resistance manifested at different time points. Importantly, the 
estrous cycle in females significantly adds some variability into the data.
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Overall mutant (het) animals had statistically significant elevated plasma insulin concentrations (median = 12, 
n = 30) after 20 weeks of age compared to WT littermates (median = 2.3, n = 35, p < 0.05) (Fig. 1D). In particular, 
Cushing’s (het) female mice developed statistically significant (p < 0.05) elevated plasma insulin concentrations 
compared to female WT littermates (Fig. 1D). Insulin secretion is triggered by elevated glucose concentration 
in the blood, supporting the hypothesis that Cushing’s mice develop a diabetic phenotype. Insulin differences 
between Cushing’s (het) male mice and male WT do not appear to be statistically significant.
Afmid (hom) male mice developed significant increased concentrations of blood glucose (p < 0.05) at the 
three time points compared to the respective WT littermates, although the increase of blood glucose levels 
with age is not statistically significant. People with impaired glucose tolerance (IGT) have plasma levels ≥ 7.8 
and < 11.1 mmol L−1 glucose29. Afmid (hom) mice show impaired glucose tolerance and Mann Whitney U test 
revealed no significant difference in plasma insulin concentration of Afmid (hom) mice and WT littermates which 
is in agreement with earlier reported21,30.
Multivariate statistical analysis on VOC emissions from stools. Discrimination of groups according 
to the phenotype – SIFT-MS and GC-MS data. The volatile faecal metabolome of the animals (wild-type (wt), 
Cushing’s (het) and Afmid (hom)) was acquired using selected ion flow tube mass spectrometry (SIFT-MS) in the 
form of m/z versus counts per second and across the three precursor ions H3O+, NO+, O2+. Follow-up using the 
canonical discriminant functions (Fig. 2) was used to determine the group membership by finding linear combi-
nations of the variables (m/z) that maximize the differences between the groups (wt, het, hom).
Overall, group separation was observed between Cushing’s (het) and Afmid (hom) mice and notably pro-
nounced on the volatile profile acquired using O2+ precursor ion. Discrimination of groups (hom, het) and the 
WT animals was not entirely clear once analysing the data sets acquired with H3O+ and NO+ precursor ions, and 
Figure 1. Changes in bodyweight (expressed in g) over the age of female and male (A) Cushing’s (het) mice and 
(B) Afmid (hom) mice compared with their respective WT littermates. Highlighted in green (het); highlighted 
in red (hom); highlighted in blue (WT) (C) Blood glucose concentrations expressed in mmol L−1 of Cushing’s 
mice (het) compared with WT littermates, age- and sex-matched groups (D) plasma insulin concentrations 
expressed in ng mL−1 of Cushing’s mice (het) compared with WT littermates, age- and sex-matched groups. 
P values were calculated between age- and sex-matched groups using student’s t-test and one-way repeated 
measures ANOVA with Bonferroni post-hoc test (◆p < 0.05, ◆◆p < 0.001); Mann Whitney’s test (#p < 0.05). 
Outliers are represented with a circle (◦) and extreme points are indicated with an asterisk (*). Error bars 
represent SEM (standard error of mean).
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therefore these findings were further investigated using partial least squares-discriminant analysis (PLS-DA) in 
conjunction with bootstrapping which provides a more robust approach.
The cross-validated classification using linear discriminant analysis (LDA) and PLS-DA results presented in 
Table 1 indicates the inter-group classification accuracy (het/WT) and the corresponding test sensitivity and spec-
ificity determined between Cushing’s (het) mice and WT littermates. Afmid (hom) knockout mice did not present 
statistically significant differences in their volatile faecal metabolome once compared to their WT littermates, on 
analysis with PLS-DA. The best classification accuracy results (het/WT) are highlighted in bold (Table 1). LDA 
was only performed on SIFT-MS data, whereas PLS-DA was performed on both data sets (SIFT-MS and GC-MS). 
The cross-validated classification showed that overall 89.2% were correctly classified using H3O+ data set at 8 
weeks of age and 86.2% were correctly classified at 20 weeks. Sensitivities and specificities are given respectively. 
The statistical analysis performed demonstrated that 83.1% were correctly classified using NO+ data set at 8 weeks 
of age and 80.9% at 12 weeks. The best classification results are given for using O2+ data set at 12 and 16 weeks of 
age, where the cross-validated classification showed an overall 85.1% and 92.2% correct classification respectively.
On analysis with PLS-DA, the best resulting data were achieved by combining data sets using H3O+, NO+ and 
O2+ at 12 weeks of age. PLS-DA score plots discriminating between WT littermates and Cushing’s (het) mice were 
determined at (a) 12 weeks of age (no Feature Selection (FS)), data acquired using SIFT-MS, Fig. 3A, and 16 weeks 
of age including range-scaling (RS1), data acquired by TD-GC-MS, Fig. 3B. According to our findings, the best 
set of predictors that discriminate between the groups (het/ WT) are indicated in Tables 2 and 3 respectively, and 
these were determined using PLS-DA multivariate analysis.
SIFT-MS (H3O+/NO+/O2+) analysis confirmed the presence of significant greater levels of m/z 61, 79 
(H3O+) (probably acetic acid since m/z 90 (NO+) is also present following the feature selection (FS) step) in 
Figure 2. Canonical discriminant functions of the first two discriminant function values, revealing 
classification of groups (wt, het, hom) according to phenotype. Number of independent observations and 
number of variables is given in Supplementary Information (Table S1). Blue markers were assigned to WT 
littermates; red markers: Cushing’s (het) diabetic animals; green markers: Afmid (hom) animals. Data acquired 
using SIFT-MS (A) H3O+, (B) NO+ and (C) O2+.
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faecal headspace of Cushing’s (het) mice at 12 weeks of age. Remarkably, these findings were supported by the 
TD-GC-MS analysis where acetic acid was found to discriminate between the groups (het/WT) at 16 weeks of 
age (Table 3). Short-chain fatty acids (SCFAs) (mainly acetate, butyrate and propionate) are produced in the gut 
by anaerobic microbial fermentation pathways9. Acetate is the major end-fermentation product in the human gut 
formed by acetogenic bacteria8. Long-chain alcohols may be originated by reduction of the corresponding acid, 
therefore acetic acid might be reduced to ethanol in the same manner31.
Statistical method SIFT-MS (Ion) Age (weeks)
Accuracy (%) Specificity (%) Sensitivity (%)
SIFT-MS GC-MS SIFT-MS GC-MS SIFT-MS GC-MS
LDA H3O+
8 89.2
N/A
91
N/A
87
N/A
12 81.5 86 77
16 75.4 83 67
20 86.2 89 83
all 71.9 76 68
LDA NO+
8 83.1
N/A
89
N/A
77
N/A
12 80.9 83 79
16 73.8 94 50
20 70.8 71 70
all 75.2 84 65
LDA O2+
8 81.5
N/A
89
N/A
73
N/A
12 85.1 87 83
16 92.2 94 90
20 72.3 86 57
all 73.0 78 68
PLS-DA H3O+/NO+/O2+
8 67.9 68.0 82.6 78.4 50.0 55.4
12 70.8 64.1 67.0 63.3 74.6 65.1
16 64.1 71.7 68.0 76.3 59.9 66.0
20 66.2 71.5 76.1 76.7 56.2 65.1
Table 1. Cross-validated linear discriminant analysis (LDA) and partial least squares-discriminant analysis 
(PLS-DA) between Cushing’s (het) mice and WT littermates. Accuracy (%) and the corresponding test 
specificity and sensitivity given for faecal headspace of Cushing’s mice. Data acquired using SIFT-MS and 
GC-MS coupled to thermal desorption (TD). H3O+/NO+/O2+ denotes the combination of the individual mass 
spectra pertaining to the three precursor ions into one dataset. The best classification results are highlighted in 
bold. N/A stands for non-applicable.
Figure 3. PLS-DA score plots discriminating between WT littermates and Cushing’s (het) mice at (A) 12 weeks 
of age including Feature Selection (FS), data acquired using SIFT-MS; (B) 16 weeks of age, data acquired by 
TD-GC-MS. Highlighted in blue is shown the WT littermates and Cushing’s (het) diabetic animals are assigned 
in red. Number of independent observations and number of variables is given in Supplementary Information 
(Tables S2 and S3).
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Regarding m/z 89 (H3O+), which is tentatively identified as butyric acid (although it could be other com-
pounds, i.e. acetoin, pyruvic acid, pentanol and methyl propionate)32, two different pathways for butyrate pro-
duction are known in butyrate-producing bacteria in human gut8,33,34. The reduced levels of butyric acid (m/z 
89 (H3O+)) found in faecal headspace of Cushing’s (het) mice might be an indicator of the reduced number of 
butyrate-producing bacteria in Cushing’s mice gut. There is previous evidence of changes in the gut microbiota of 
type-2 diabetic patients when compared to non-diabetic subject17. An earlier investigation reported that patients 
with type-2 diabetes had less butyrate-producing bacteria than controls35,36. However, ethnic factors, dietary dif-
ferences, and intake of medication might take an important role on studies’ discrepancies previously reported.
The existence of increased levels of acetone in Cushing’s mice faecal headspace was supported and validated 
by the TD-GC-MS analysis, and probably arise from-fatty acid and carbohydrate metabolism in the liver. The ion 
m/z 47 (H3O+) is very likely ethanol, and this results from the breakdown of carbohydrates by bacteria in the gut9. 
Using the chromatographic capabilities of TD-GC-MS, butyric acid, ethyl ester and butyric acid, 2-methyl were 
identified as predictor ions for the discrimination of the groups (WT/het).
There is evidence of three different pathways used by colonic bacteria for propionate formation in human gut, 
i.e. succinate pathway, acrylate pathway and propanediol pathway. Nevertheless, propionate is mostly formed via 
the succinate pathway by Bacteroidetes and by some Firmicutes8,37. Significantly increased levels of propanoic acid, 
ethyl ester were found in Cushing’s (het) mice faecal headspace. Faecal SCFAs concentration in healthy humans 
strongly depend on the dietary regime, medication, age, and genetic background38, and elevated levels of SCFAs 
were observed in obese humans39. Other studies have demonstrated that SCFAs directly contribute to host pro-
tection from metabolic diseases. In particular, SCFAs were administrated in mice, and the findings suggested that 
butyrate, propionate and acetate protect against diet induced obesity and insulin resistance40,41. Butyrate and pro-
pionate, but not acetate, induce gut hormones and reduce food intake, reduces inflammation and consequently 
insulin resistance40,42. Acetic acid seems to beneficially affect glucose metabolism by reducing hyperglycaemia 
and supressing appetite in mice43,44. By contrast, a recent and detailed study reported changes to gut microbiota, 
and altered faecal SCFAs concentrations which promoted the metabolic syndrome, insulin resistance and obesity, 
through the activation of the parasympathetic nervous system14. Interestingly the authors found increased pro-
duction of acetate in rodents on a high-fat diet which in turn promoted increased glucose output and stimulated 
the secretion of insulin and ghrelin hormone triggering increased appetite and promoting obesity. They have 
also observed plasma and faecal acetate concentrations significantly increased in insulin-resistant rats after three 
days or four weeks on a high-fat diet, driving obesity and insulin resistance. Our findings are consistent with the 
previous report14,15, wherein differences in acetic acid differ remarkably between the faecal headspace of WT 
littermates and those of Cushing’s mice, either by SIFT-MS and TD-GC-MS. Cushing’s mice developed obesity 
and showed significantly higher blood glucose concentrations and plasma insulin concentrations, supporting the 
hypothesis that Cushing’s mice develop a diabetic phenotype related to a gut microbiota interaction.
m/z (H3O+/NO+/O2+)
SIFT-MS
Compound
47 (H3O+) Ethanol/ formic acid
59 (H3O+) Acetone/Propanol
65 (H3O+) Ethanol
77 (H3O+) Acetone
61, 79 (H3O+) Acetic acid/propanol
89 (H3O+) Butyric acid/acetoin/pyruvic acid/pentanol/methyl propionate
31 (O2+) By-product of methanol or ethanol
Table 2. PLS-DA statistical analysis in faecal headspace and respective m/z ions and probable compounds 
that discriminate the groups (WT/het). Data acquired by SIFT-MS (12 weeks). H3O+/NO+/O2+ denotes the 
combination of the individual mass spectra pertaining to the three precursor ions into one dataset.
RT (min) CAS
TD-GC-MS
Compound
4.277 56893 Unknown
6.585 67641 Acetone
9.707 431038 2,3-Butanedione
10.861 64197 Acetic acid
12.011 105373 Propanoic acid, ethyl ester
12.244 105544 Butyric acid, ethyl ester
15.074 116530 Butyric acid, 2-methyl
Table 3. PLS-DA statistical analysis in faecal headspace and respective retention time (RT) and probable 
compounds that discriminate the groups (WT/het). Data acquired by TD-GC-MS (16 weeks). Retention time 
(RT) is given in minutes and its chemical abstract service number (CAS).
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Discrimination of groups throughout the ageing process – SIFT-MS and GC-MS data. Not only has the discrimi-
nant analysis provided insight of the discrimination of groups according to the phenotype, but also whether the 
volatile profile is able to discriminate groups according to the ageing process. These findings might be linked to 
previous evidence of age-related changes in gut microbiota composition45,46. The best resulting data were achieved 
by combining data sets using H3O+, NO+ and O2+ using PLS-DA pre-subjected to principal components analysis 
(PCA) and discriminating between 12 weeks and 20 weeks of age (Cushing’s (het) mice) (Fig. 4A). An overall 
classification accuracy indicated that 73% grouped cases were correctly classified which had a specificity of 59% 
and a sensitivity of 83%.
Permutation analysis (Fig. 4B) suggests that the performance metrics obtained were not due to chance. 
Acetone was found to increase significantly with age. The ions m/z 77 (H3O+) and m/z 58 (O2+) are likely to 
be acetone and probably arise from-fatty acid and carbohydrate metabolism31. The breakdown of carbohy-
drates by bacteria in the gut is performed by several different genera including Bacteroides, Lactobacillus and 
Bifidobacterium47. The main degradation products are short-chain fatty acids (SCFAs) (mainly acetate, propionate 
and butyrate), lactate and other products including CO2, H2, CH4 and ethanol9. The set of ions responsible for the 
discrimination include m/z 65, m/z 83 (H3O+) and m/z 63 (NO+), which are likely ethanol, whereas the ions m/z 
51, m/z 69 (H3O+) are likely methanol. The identity of ion m/z 63 (O2+) has not been established but it was one of 
the ions responsible for the discrimination.
Afmid (hom) knockout mice did not present statistically significant differences in their volatile faecal metab-
olome once compared to their WT littermates, on analysis with PLS-DA. Whereas, discrimination of groups 
according to the ageing process was observed throughout the age (8–12, 8–16, 12–16 weeks), with classifica-
tion accuracies exceeding 75%. Based on highest accuracy and highest sensitivity observed between 12 weeks 
and 16 weeks of age in knockout Afmid (hom) mice (TD-GC-MS data sets), the best set of compounds that 
discriminate the two age groups are 2-butanone, 3-hydroxy also known as acetoin; pyridine-3-carboamide and 
1,3-dioxalane, 2-methyl. Interestingly, there is evidence that acetoin (2-butanone, 3-hydroxy) is a product of fer-
mentation in bacteria48,49. Bacillus subtilis, Bacillus amyloliquefaciens, Enterobacter cloacae, Serratia marcescens, 
and Paenibacillus polymyxa, can produce acetoin from pyruvate via α-acetolactate by two enzymatic steps cat-
alysed by α-acetolactate synthase and α-acetolactate decarboxylase48, and consequently acetoin can be further 
converted to 2,3-butanediol50. The remaining compounds, pyridine-3-carboamide and 1,3-dioxalane, 2-methyl 
cannot be easily attributed to any specific metabolic pathways.
Comparative analysis of the volatile faecal metabolome in type 2 diabetes mouse models. Our findings suggested 
that Afmid (hom) mice and Cushing’s (het) mice have differences in regards to their volatile faecal metabolome 
and the PLS-DA model successfully classified them according to the phenotype. Using SIFT-MS, the loadings 
responsible in providing the highest discrimination between the groups Afmid (hom) mice and Cushing’s (het) 
mice are m/z 61, m/z 79 (H3O+) tentatively identified as acetic acid, and m/z 89 (H3O+) potentially identified as 
methyl propionate/ pentanol/ ethyl acetate/ butyric acid. Increased levels of m/z 89 (H3O+) were found in Afmid 
(hom) mice once compared to Cushing’s mice, whereas m/z 61 and m/z 79 increased levels of these ions were 
found in Cushing’s (het) mice, potentially indicating that further decomposition onto butyric acid is limited by 
the number and survival rate of butyrate-producing bacteria in the mouse gut. Earlier evidence demonstrated 
Figure 4. PLS-DA score plot discriminating between 12 and 20 weeks of age in Cushing’s (het) mice; 
highlighted in blue is shown the 12 weeks group and 20 weeks group in red (A) Permutation results 
demonstrating that reported performance metrics were not due to chance (B) as illustrated by the distance 
between the maximum peaks of the two density distributions. Data acquired with SIFT-MS (H3O+, NO+ and 
O2+). Number of independent observations and number of variables is given in Supplementary Information 
(Table S2).
8Scientific RepoRtS |         (2019) 9:18779  | https://doi.org/10.1038/s41598-019-55339-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
the importance of the gut microbiota in the development of obesity and the onset of diabetes in mice, where an 
increased ratio of Bacteroidetes and the Firmicutes was found in genetically obese mice and associated with an 
increased faecal concentration of the major fermentation end-products acetate and butyrate, when compared to 
lean littermates; and faecal transplants from mice with glucose intolerance into healthy germ-free mice induced 
glucose intolerance15,51.
The studied mouse models differ in terms of their volatile metabolic profile, and age-related changes in the 
volatile pattern seem to be significant. PLS-DA score plots showed the discrimination between Afmid (hom) mice 
and Cushing’s (het) mice over the age (Fig. 5).
Age-related changes between Afmid (hom) mice and Cushing’s (het) mice were investigated here and over-
all good classification results ranging from 93.1% (8 weeks), specificity 96.5% and sensitivity 90.2%; 87.2% (12 
weeks) specificity 87.2% and sensitivity 87.2% and 91.5% (16 weeks) specificity 92.9% and sensitivity 90.7% were 
determined. The volatile metabolic profile of the animals seem to differ the most in an early life stage (8 weeks) 
further developing diverse volatile patterns over the age (up to 16 weeks of age). The set of compounds respon-
sible for discriminating longitudinal changes in the volatile faecal metabolome between the two different mouse 
models is indicated in Table 4. These are the most likely identification of compounds, however the match is low in 
some cases and the metabolic pathways for some are unclear.
Conclusion
The present study aimed to investigate the volatile faecal profile in two type 2 diabetes mouse models – Cushing’s 
syndrome and single Afmid knockout mice – using selected ion flow tube mass spectrometry (SIFT-MS) and gas 
chromatography-mass spectrometry combined with thermal desorption (TD-GC-MS).
Univariate and multivariate data analysis, complementary statistical techniques, have proven to be a robust 
tool in the study of gut metabolomics. The gut microbiota of Cushing’s diabetic mice seem to have a different 
composition once compared to wild-type (WT) littermates, and statistically significant differences in volatile 
faecal metabolites, including short-chain fatty acids (SCFAs), alcohols and ketones. Afmid (hom) knockout mice 
did not present statistically significant differences in their volatile faecal metabolome when compared to their 
respective WT littermates.
Discriminant analysis upon the ageing group demonstrated the incidence of changes in the longitudinal 
volatile faecal metabolome of Cushing’s diabetic mice, mainly attributed to methanol, ethanol and acetone. 
Longitudinal volatile changes in Afmid mice were shown to be attributed to 2-butanone, 3-hydroxy also known as 
acetoin; pyridine-3-carboamide and 1,3-dioxalane, 2-methyl.
A comparative multivariate data analysis of the volatile faecal metabolome in type 2 diabetes mouse mod-
els showed differences mainly in terms of acetic acid and butyric acid. Reduced levels of m/z 89 (H3O+) ten-
tatively identified as butyric acid were found in Cushing’s mice once compared to both WT littermates and 
Afmid mice, potentially indicating that further decomposition onto butyric acid is limited by the number of 
butyrate-producing bacteria in the animals’ gut. While, m/z 61 and m/z 79 (H3O+) (tentatively identified as acetic 
acid) increased levels of these ions were found in diabetic Cushing’s mice faecal headspace once compared to 
both WT littermates and Afmid mice, which is consistent with earlier reported. All the animals were housed in 
the same environment and fed ad libitum on the same commercial diet, and importantly, WT littermates present 
an identical genetic background as to the respective diabetic animals. Therefore, these findings suggest that mice 
developed a diabetic phenotype and that the altered VOC profile may imply a related change in gut microbiota, 
particularly in Cushing’s mice. Furthermore, this study provided major evidence of age-related changes on the 
volatile profile of diabetic mice.
Figure 5. PLS-DA score plot discriminating between Afmid (hom) mice and Cushing’s (het) mice over the age. 
Data acquired using TD-GC-MS. Highlighted in blue is shown the “hom” animals and in red the “het” animals. 
8 weeks: Classification of 93.1%, specificity 96.5% and sensitivity 90.2%; 12 weeks: Classification of 87.2%, 
specificity 87.2% and sensitivity 87.2%; 16 weeks: Classification of 91.5%, specificity 92.9% and sensitivity 
90.7%. Number of independent observations and number of variables is given in Supplementary Information 
(Table S3).
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Methods
Animals. Male heterozygous (het) Crh−120/+ mice on a B6-C3PDE F1 background were backcrossed to 
B6-C3PDE F1 female wild-type mice to produce progeny which were screened for phenotypes and classified as 
mutant Cushing’s (het) mice and wild-type (WT) littermates. A cohort of 65 animals (21 male and 44 female) was 
used of whom 30 were genotyped as mutants (het) and 35 WT littermates6.
A cohort of 48 homozygous (hom) knockout (Afmidtm1b/tm1b) mice (24 male and 24 female) on a C57BL6/
NTac background were bred which were screened for phenotypes of whom 30 were genotyped as mutants (hom) 
and 18 wild-type (WT) littermates.
Mice were maintained in controlled light (12 h light and dark cycle), temperature (21 ± 2 °C) and humidity 
(55 ± 10%). Mice had free access to water (10–12 ppm chlorine) and were fed ad libitum on a commercial diet 
(5.3% fat [corn oil], 21.2% protein, 57.4% carbohydrate, 4.6% fibre; Rat and Mouse Diet No. 3 (RM3), Special Diet 
Services, Essex, UK)6. All mice were housed in groups of 2–5 mice of the same gender. Adult (8 weeks of age) 
Cushing’s mice were tested over four months (8, 12, 16 and 20 weeks of age) while adult (8 weeks of age) Afmid 
mice were tested over a three month period (8, 12 and 16 weeks of age). Stool pellets were collected from all the 
animals and the VOCs emanated from the stool pellets were analysed further. Blood glucose analysis was carried 
out simultaneously (details are given below).
All animal studies were carried out using guidelines issued by the United Kingdom (UK) Medical Research 
Council (MRC), in Responsibility in use of Animals for Medical Research (July 1993), and the requirements of 
Home Office Project License number 30/3146. The experimental protocols were approved by the MRC Harwell 
Institute Animal Welfare and Ethical Review Body (AWERB). All animal studies were carried out at the Mary 
Lyon Centre (Harwell, UK)6.
Stool collection. Stool samples were collected from each mouse at various times for analysis of VOCs. 
Animals were individually housed in metabolic cages (Techniplast Kettering, UK) for 30 minutes or until suffi-
cient gathering of stool, i.e. six pellets per animal. The mice were fed ad libitum on water (10–12 ppm chlorine) 
and powdered chow (RM3, Special Diet Services Essex, UK). Autoclavable red transparent igloos (Datesand Ltd, 
Manchester, UK) were provided as environmental enrichment. Faecal samples were collected into Eppendorf 
containers, and these were immediately frozen at −20 °C. Faecal samples were then transported to The Open 
University in dry ice and kept at −80 °C until further analysis.
Blood and plasma biochemistry. Animal bodyweight was measured (precision balance OHAUS Explorer 
Pro EP213 ± 0.001 g accuracy) and recorded prior to analysis and over the duration of the study. Blood samples 
were taken on the same days as faecal samples and were taken from the lateral tail vein following application of 
topical local anaesthesia (EMLA cream) leaving it to work for 15 minutes, and while mice were restrained in a 
Perspex bleeding tube. Blood glucose levels were measured at the same period of the day, specifically between 
2 pm and 4 pm, using a blood glucose monitoring system (AlphaTRAK2)6.
In order to evaluate the insulin levels in mice, plasma concentrations in blood were measured after terminal 
bleeding of the animals. Therefore, the plasma insulin concentrations for Cushing’s mice and respective WT lit-
termates do not correspond to 20 weeks of age but a later stage once the animals were culled, i.e. animals born in 
Age (weeks) RT (min) Most probable compound AMDIS (%)
8
3.093 Unknown 14.1
3.950 Unknown 38.9
4.145 Acetaldehyde 75.5
10.053 2,3-butanedione 74.9
23.877 2-hexadecanol 33.5
25.147 Bicyclopropyl-2-octanoic acid 15.3
12
4.308 Unknown 32.8
6.806 Acetone 88.4
9.545 2,3-butanedione 64.3
5.783 Pentane 13.3
17.804 Piperidine, 1,3-dimethyl 37.5
19.383 Cyclopropanetetradecanoic acid 22.3
19.906 Benzene, 1,3-bis(1,1-dimethylethyl)- 12.3
16
4.220 Acetaldehyde 25.0
9.459 2,3-butanedione 78.6
10.513 Acetic acid, ethanyl ester 15.5
17.957 Nonanal 35.4
15.185 Unknown 8.64
Table 4. Set of predictors discriminating longitudinal changes in the volatile faecal metabolome between Afmid 
(hom) mice and Cushing’s (het) mice. TD-GC-MS data analysed using PLS-DA. Retention time (RT) is given in 
minutes, AMDIS probabilities (%).
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April and May were culled at 28 weeks of age, and animals born in June were culled at 24 weeks of age. Similarly, 
plasma insulin concentrations for Afmid mice and respective WT littermates do not correspond to 16 weeks of 
age, i.e. animals born in March were culled at 32 weeks of age, and animals born in May were culled at 28 weeks 
of age. An enzyme-linked immunosorbent assay (ELISA) kit (Cat no. EZRMI-13K) was used and the range of the 
assay set between 0 and 15 ng mL−1. The insulin concentration of three animals were above the upper limit for the 
ELISA assay thus a value of 15 ng mL−1 was assigned for these animals6.
VOC sampling and faecal headspace analysis. Selected ion flow tube mass spectrometry (SIFT-MS) 
enables direct, real-time monitoring of VOCs, and the SIFT analytical technique has been described in detail 
previously52. Data were collected using the Mk2 instrument (PDZ Europa, UK) with a flow rate of corresponding 
to a pressure of 0.008 Torr (the flow tube pressure of 1 mbar (0.7 Torr) and a flow rate of 53 sccm). Six pellets 
per animal were placed inside Nalophan bags (35 cm long Nalophan sampling bag, made up of 65 mm diameter 
Nalophan NA tubing 25 µm thick (Kalle UK)); sample bags were sealed and filled with hydrocarbon free air (Air 
Products); after 1 hour of incubation at 37 °C, the bags were connected to the SIFT-MS via the heated sampling 
line and the faecal headspace further analysed. The normalisation of the data corrects for the variation in sample 
weight. Samples were analysed in random order and full spectra of the count rates in the range m/z 10 to m/z 140 
were recorded for all the samples via H3O+, NO+ and O2+ precursor ions, using the Full Scan mode and a total 
sample time of 30 seconds. Background laboratory air was also analysed.
After the faecal headspace analysis by SIFT-MS, the sample headspaces containing VOCs were pumped into 
pre-conditioned stainless-steel thermal desorption sorbent tubes (Markes International Ltd) and analysed by gas 
chromatography-mass spectrometry (GC-MS) coupled to thermal desorption (TD). The detailed approach is 
given below.
Gas chromatography-mass spectrometry combined with thermal desorption (TD-GC-MS) has been widely 
used for trace gas analysis in human health monitoring24,53–55 and the working principle has been described in 
detail elsewhere56. VOCs were pumped into pre-conditioned stainless-steel TD sorbent tubes for 5 min at a con-
stant flow of 100 mL min−1 (Pump TSI Inc. SidePak Model SP730). These stainless-steel tubes without inert coat-
ing were used and had dual packing comprising of 40% Tenax TA and 60% Carbotrap (Markes International 
Ltd). Prior to analysis, the tubes were spiked with 1 µL of internal standard, d8-toluene (50 ng) in methanol, and 
were then flushed with nitrogen for 30 sec. All samples were analysed in random order according to the method 
described below.
Chromatographic analyses were performed using an Agilent 6890/5973 GC-MS system equipped with an 
Ultra 2 autosampler and UNITY model 1 thermal desorber (Markes International Ltd). The tubes were submitted 
to a pre-purge of 1.0 min, followed by desorption at 260 °C for 3.0 min. The trap temperature was set at −7 °C and 
the actual trap desorption occurred at 300 °C for 3.0 min. The volatiles were separated using an Rxi-624 Sil MS 
column (60 m × 0.32 mm, film thickness 1.8 µm, Restek) working in a constant flow mode. The column temper-
ature program involved an initial increase from 35 °C to 60 °C at a rate of 11 °C min−1, followed by a rate of 20 °C 
min−1 up to 220 °C, and a constant temperature of 220 °C for 10 min. The mass spectrometer was operated in a 
SCAN mode with an associated m/z range set from 33.0 to 260.0. The transfer line, ion source and quadrupole 
temperature were kept at 230 °C, 230 °C and 150 °C, respectively.
Data processing. Prior to data analysis, the counts per second acquired by SIFT-MS were normalised against 
the counts per second of the H3O+ (m/z 19) precursor ions. The H3O+ (m/z 19) ions react with the gas sample 
producing the hydrated ions H316O+(H2O)n, n = 1,2,3 corresponding to m/z 37, 55, 73. The humidity levels found 
in the gas samples were evaluated, i.e. the average fraction of counts per second between the ions m/z 19, 37, 
55, 73 and respective isotopes, 17O (m/z 20, 38, 56, 74), and 18O (m/z 21, 39, 57, 75) according to earlier litera-
ture57. The fractions of the larger cluster ions will likely increase with increasing water vapour57. The fractions 
remained relatively constant (same order of magnitude) across the different age groups (Tables S4 and S5 given 
in Supplementary Information). This provides reasonable evidence that humidity does not vary too much in the 
samples, therefore the authors consider this is not critical, although normalisation to the total ion count would 
be more accurate.
All m/z values pertaining to the known isotopologue and hydrate ions (i.e. m/z values: 19, 21, 30, 32, 34, 37, 39, 
48, 55, 57, 66, 73, 75, and 91) were removed, except for the linear discriminant analysis (LDA)/canonical discri-
minant functions. Principal components analysis (PCA)58 was employed to visually identify any outlying samples, 
and to carry out feature selection (FS) by omitting redundant variables. For comparison, no feature selection was 
also carried out. There was little improvement in specificity and sensitivity when using the feature selection.
TD-GC-MS data analysis was performed through the aid of AMDIS (Automated Mass Spectral Deconvolution 
and Identification System) software, and followed by reliable identification of compounds using the NIST 
(National Institute of Standards and Technology) library. Prior to multivariate statistical data analysis, the data 
was normalised against the internal standard. Principal components analysis (PCA)58 was employed to visually 
identify any outlying samples. The chromatographic peaks were aligned via the correlation optimised warping 
(COW) algorithm59,60.
For both SIFT-MS and GC-MS, additional scaling was carried out to investigate the effects on the performance 
metrics; these involved auto-scaling (AS), range-scaling (RS) and normalisation (NRM)61.
Statistical analysis. Univariate statistical analysis was carried out using student’s t-test (normally distrib-
uted data); Mann-Whitney U test, Wilcoxon Signed Rank Test using a Bonferroni adjusted p value (p < 0.001) 
and Friedman test were used when appropriate for “distribution-free” data; and one-way repeated measures 
ANOVA with Bonferroni post-hoc test. Testing corrections such as Bonferroni post-hoc tests are used to reduce 
the number of false positives.
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Multivariate statistics was performed and a predictive model was built for group membership by linear dis-
criminant analysis (LDA)62, such model is based on combinations of the predictor variables that provide the best 
discrimination between the groups. Follow-up using canonical discriminant functions was performed. All the 
variables (m/z) were transformed using the square root transformation to convert the distribution from “skewed” 
to “normal”, followed by standardization of the data sets, i.e. m/z values were mean-centred and divided by the 
respective standard deviation of each data set. The univariate statistical analysis, LDA and canonical discriminant 
functions were performed using the software IBM SPSS Statistics 21.0.
LDA was performed, where two or more groups are known a priori and these are classified into one of the 
known populations based on the measured features. LDA is a supervised technique in which a mathematical 
model is created in which patterns within the independent data (e.g. SIFT-MS m/z ions) are related to the depend-
ent (response) variables, in this case the population groups consisting of wild-type and either “het” for Cushing or 
“hom” for Afmid. LDA is also said to be a “hard classifier” in which there needs to be a distinctive (linear) separa-
tion between the two population groups.
Partial least squares-discriminant analysis (PLS-DA)63 works in the same manner as LDA but is said to be a 
“soft classifier” in which samples are classified into the population groups by probability. The partial least squares 
(PLS) decomposes the independent data into a scores and loadings matrix in a similar approach to principal 
components analysis (PCA)58, but in which latent variables (LVs) form a new coordinate system in which the first 
latent variable (i.e. LV1) contains the most characteristic information pertaining to the data, i.e. has the highest 
variance63. The PLS scores relate the population groups whilst the PLS loadings indicate the significant variables, 
e.g. SIFT-MS m/z ions, that contribute to the distinction between the two population groups.
PLS-DA was performed in conjunction with bootstrapping. This involved randomly splitting the dataset into 
two groups: 70% as a training set; 30% as a testing set, ensuring both sets were balanced. An optimum PLS-DA 
model was attained via optimisation with leave-one-out cross-validation (LOO-CV). This optimum model is then 
used to predict the classification of the testing set. The performance metrics of the model is determined by calcu-
lating the accuracy, specificity and sensitivity. The process is repeated 150 times to attain an overall performance. 
A script written in R software64 carried out the analyses using the pls.lda() function from the plsgenomics pack-
age65. At the same time, permutation analysis was performed in which the population groups were randomised in 
order to ensure that the performance metrics attained above were not due to chance.
Ethical approval. All applicable international, national, and/or institutional guidelines for the care and use 
of animals were followed. All procedures performed in studies involving animals were in accordance with the 
ethical standards of the institution or practice at which the studies were conducted.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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